In Vitro Performance of Two Common Valved Holding Chambers with a Chlorofluorocarbon-Free Beclomethasone Metered-Dose Inhaler

Pharmacotherapy

Volumn 23, Issue 12 I, 2003, Pages 1538-1544

  Asmus, Michael J ^a   Coowanitwong, Intira ^a   Hun Kwon, Soo ^a   Khorsand, Nakisa ^a   Hochhaus, Günther ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Asthma; Beclomethasone; Holding chamber; Metered dose inhaler

Indexed keywords

BECLOMETASONE DIPROPIONATE; CHLOROFLUOROCARBON; PROPELLANT;

AEROSOL; ARTICLE; ASTHMA; DRUG DELIVERY SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; METERED DOSE INHALER; PERFORMANCE; VALVED HOLDING CHAMBER;

AEROSOL PROPELLANTS; ANTI-ASTHMATIC AGENTS; BECLOMETHASONE; EQUIPMENT DESIGN; HYDROCARBONS, FLUORINATED; METERED DOSE INHALERS;

EID: 0344011154     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.15.1538.31960     Document Type: Article

References (34)

1. O'Byrne PM. Clinical comparisons of inhaler systems: what are the important aspects? J Aerosol Med 1995;8(suppl 3):S39-46.
2. Newman SP, Newhouse MT. Effect of add-on devices for aerosol drug delivery: deposition studies and clinical aspects. J Aerosol Med 1996;9:55-70.
3. Kenyon CJ, Dewsbury NJ, Newman SP. Differences in aerodynamic particle size distributions of innovator and generic beclomethasone dipropionate aerosols used with and without large volume spacers. Thorax 1995;50:846-50.
4. Finlay WH, Zuberbuhler P, Mandl M. Particle size measurements for the space chamber metered dose inhaler holding chamber compared with aerochamber and metered dose inhaler alone. J Aerosol Med 1997;10:213-19.
5. Berg E, Madsen J, Bisgaard H. In vitro performance of three combinations of spacers and pressurized metered dose inhalers for treatment in children. Eur Respir J 1998;12:472-6.
6. Dalby RN, Somaraju S, Chavan VS, et al. Evaluation of aerosol drug output from the optichamber and aerochamber spacers in a model system. J Asthma 1998;35:173-7.
7. Barry PW, O'Callaghan C. A comparative analysis of the particle size output of beclomethasone dipropionate, salmeterol xinafoate and fluticasone propionate metered dose inhalers used with the babyhaler, volumatic and aerochamber spacer devices. Br J Clin Pharmacol 1999;47:357-60.
8. Berlinski A, Waldrep JC. Metering performance of several metered-dose inhalers with different spacers/holding chambers. J Aerosol Med 2001;14:427-32.
9. Asmus MJ, Liang J, Coowanitwong I, et al. In vitro deposition of fluticasone aerosol from a metered-dose inhaler with and without two common valved holding chambers. Ann Allergy Asthma Immunol 2002;88:204-8.
10. Ahrens R, Lux C, Bahl T, et al. Choosing the metered-dose inhaler spacer or holding chamber that matches the patient's need: evidence that specific drug being delivered is an important consideration. J Allergy Clin Immunol 1995;96:288-94.
11. Barry PW, O'Callaghan C. Inhalation drug delivery from seven different spacer devices. Thorax 1996;51:835-40.
12. Wilkes W, Fink J, Dhand R. Selecting an accessory device with a metered-dose inhaler: variable influence of accessory devices on fine particle dose, throat deposition, and drug delivery with asynchronous actuation from a metered-dose inhaler. J Aerosol Med 2001;14:351-60.
13. McDonald KJ, Martin GP. Transition to CFC-free metered dose inhalers: into the new millennium. Int J Pharm 2000;201:89-107.
14. Alexander DJ. Safety of propellants. J Aerosol Med 1995;8(suppl 1):S29-34.
15. Leach CL. Improved delivery of inhaled steroids to the large and small airways. Respir Med 1998;92(suppl A):3-8.
16. Purewal TS. Alternative propellants for metered dose inhalers. Aero Spray Rep 1998;37:20-5.
17. Rahmatalla MF, Zuberbuhler PC, Lange CF, Finlay WH. In vitro effect of a holding chamber on the mouth-throat deposition of QVAR (hydrofluoroalkane-beclomethasone dipropionate). J Aerosol Med 2002;15:379-85.
18. Olson B. Can in vitro measurements predict the lung deposition of dry-powder inhalers. J Aerosol Med 1997;10: S13-16.
19. The United States Pharmacopeial Convention. Physical tests and determinations: aerosols, metered-dose inhalers, and dry-powder inhalers. In: The United States pharmacopeia, 25th ed. Rockville, MD: USP Convention, 2001:1964-80.
20. Phelan RF, Cuddihy RG, Fisher GL, et al. Main features of the proposed NCRP respiratory tract model. Radiat Prot Dosimetry 1991;38:179-84.
21. Task Group on Lung Dynamics. Deposition and retention models for internal dosimetry of the human respiratory tract. Health Phys 1966;12:173-208.
22. 3M Pharmaceuticals. QVAR (beclomethasone dipropionate HFA, 80-μg inhalation aerosol) package insert. Northridge, CA; 2000.
23. Pierart F, Wildhaber JH, Vrancken I, et al. Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. Eur Respir J 1999;13:673-8.
24. Mulholland M, Rudd DR. Development and validation of an HPLC assay method for the simultaneous determination of beclomethasone dipropionate, beclomethasone 17-monopropionate, beclomethasone 21-monopropionate, and beclomethasone in beclomethasone dipropionate drug substance. Anal Proc 1985;22:140-1.
25. Taylor SA, Asmus MJ, Liang J, Coowanitwong I, Vafadari R, Hochhaus G. Performance of a corticosteroid inhaler with a spacer fashioned from a plastic cold-drink bottle: effects of changing bottle volume. J Asthma 2003;40:237-42.
26. Barry PW, O'Callaghan C. Optimum length and width for a spacer device. Pharm Pharmacol Comm 2000;6:1-5.
27. Zak M, Madsen J, Berg E, Bulow J, Bisgaard H. A mathematical model of aerosol holding chambers. J Aerosol Med 1999;12:187-96.
28. Bisgaard H. A metal aerosol holding chamber devised for young children with asthma. Eur Respir J 1995;8:856-60.
29. Feddah MR, Davies NM, Gipps EM, et al. Influence of respiratory spacer devices on aerodynamic particle size distribution and fine particle mass of beclomethasone from metered-dose inhalers. J Aerosol Med 2001;14:477-85.
30. Smith KJ, Chan HK, Brown KF. Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers. J Aerosol Med 1998;11:231-45.
31. Davies N, Feddah M, Brown K, et al. In vitro characterization of metered dose inhaler versus dry powder inhaler glucocorticoid products: influence of inspiratory flow rates. J Pharm Sci 2000;3:318-24.
32. Bousquet J, Ben-Joseph R, Messonnier M, et al. A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma. Clin Ther 2002;24:1-20.
33. Martin RJ, Szefler SJ, Chinchilli VM, et al. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med 2002;165:1377-83.
34. Derendorf H, Hochhaus G, Meibohm B, et al. Pharmacokinetics and pharmacodynamics of inhaled corticosteroids. J Allergy Clin Immunol 1998;101:S440-6.